CherryCircle Software offers QbDVision, a cloud platform that applies quality-by-design principles to manage complex pharmaceutical manufacturing development and reduce development time and systemic failure risk. The company uses serverless technologies and automated testing tools to enable rapid development and deployment of secure, validated software solutions that support process and data management with strong data integrity. Its product is aimed at increasingly complex drug-manufacturing workflows, including emerging cell and gene therapies, and is designed to collect and interpret data from multiple sources. CherryCircle emphasizes capturing development knowledge over time and driving development decisions with data rather than documents. The company is an active member of the International Society for Pharmaceutical Engineering (ISPE). CherryCircle raised $2.3 million in seed funding to support growth plans.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Feb 2019